All In MedTech

Device Trial Radar · NCT05787821

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study A Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

760

Planned (sponsor's estimate)

Start

Jun 28, 2023

Primary completion

Jun 30, 2026

Study completion Jun 2035

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Mar 28, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

Conditions

  • Knee Pain Chronic
  • Osteoarthritis, Knee
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Polyarthritis
  • Varus Deformity
  • Valgus Deformity
  • Flexion Deformity of Knee
  • Avascular Necrosis

Interventions

  • Total Knee ArthroplastyDevice

    Total knee replacement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Oxford Knee Score (OKS)Time frame: 5 years

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Denver Hip & Knee, Inc.

    Parker, Colorado

  • Foundation for Orthopaedic Research & Education

    Tampa, Florida

  • Northside Hospital, Inc.

    Atlanta, Georgia

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.